Abstract
Infection begins when microorganisms overcome host barriers and multiply within host tissue. In an effort to contain infection, the host stages an inflammatory reaction to mobilize defense systems and kill the invading microorganisms. In most cases, the activated defense mechanisms lead to eradication of infection through a localized inflammatory reaction. However, when the infectious stimulus cannot be contained within tissues, infectious agents, their toxins, and host-derived mediators are released into the circulation leading to a systemic inflammatory response syndrome and remote organ dysfunction [1]. The pathogenesis of sepsis assumes that microorganisms lead to organ failure through a common pathway of injury. Over the past decade, a large number of host-derived inflammatory mediators have been discovered and implicated in the pathogenesis of sepsis. These mediators have pro-and/or anti-inflammatory efficacy and are interrelated through complex potentiating and inhibiting pathways with each other [2].
Keywords
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Natanson C, Hoffman WD, Suffredini AF, Eichacker PQ, Danner R (1994) Selected treatment strategies for septic shock based on proposed mechanisms of pathogenesis. Ann Intern Med 120:771–783.
Blackwell TS, Christman JW (1996) Sepsis and cytokines: current status. Br J Anaesth 77: 110–117.
Natanson C, Danner RL, Elin RJ, et al (1989) Role of endotoxemia in cardiovascular dysfunction and mortality: Escherichia coli and Staphylococcus aureus challenges in a canine model of human septic shock. J Clin Invest 83:243–251.
Danner RL, Natanson C, Elin RJ, et al (1990) Pseudomonas aeruginosa compared with Escherichia coli produces less endotoxemia but more cardiovascular dysfunction and mortality in a canine model of septic shock. Chest 98:1480–1487.
Ahmed AJ, Kruse JA, Haupt MT, Chandrasekar PH, Carlson RW (1991) Hemodynamic responses to gram-positive versus gram-negative sepsis in critically ill patients with and without circulatory shock. Crit Care Med 19:1520–1525.
Eichenholz PW, Eichacker PQ, Hoffman WD, et al (1992) Tumor necrosis factor challenges in canines: Patterns of cardiovascular dysfunction. Am J Physiol 263: H668–H675.
Natanson C, Eichenholz PW, Danner RL, et al (1989) Endotoxin and tumor necrosis factor challenges in dogs simulate the cardiovascular profile of human septic shock. J Exp Med 169: 823–832.
Zeni F, Freeman BD, Natanson C (1997) Antiinflammatory therapies to treat sepsis and septic shock—A reassessment. Crit Care Med 25:1095–1100.
Karzai W, Reinhart K (1997) Immune modulation and sepsis. Int J Clin Pract 51:232–237.
Suffredini AF, Fromm RE, Parker MM, et al (1989) The cardiovascular response of normal humans to the administration of endotoxin. N Engl J Med 321:280–287.
Bone RC (1993) How gram-positive organisms cause sepsis. J Crit Care 8:51–59.
Walmrath D, Pilch J, Scharmann M, Grimminger F, Seeger W (1994) Severe VA/Q mismatch in perfused lungs evoked by sequential challenge with endotoxin and E. coli hemolysin. J Appl Physiol 76:1020–1030.
Walmrath D, Scharmann M, Konig R, Pilch J, Grimminger F, Seeger W (1993) Staphylococcal alphin induced ventilation-perfusion mismatch in isolated blood-free perfused rabbit lungs. J Appl Physiol 74:1972–1980.
Walmrath D, Griebner M, Kolb B, et al (1993) Endotoxin primes perfused rabbit lungs for enhanced vasoconstrictor response to staphylococcal alpha-toxin. Am Rev Respir Dis 148: 1179–1186.
Wilson M, Seymour R, Henderson B (1998) Bacterial perturbation of cytokine networks. Infect Immun 66:2401–2409.
Kotwal GJ (1997) Microorganisms and their interaction with the immune system. J Leukoc Biol 62:415–429.
Beuscher HU, Rodel F, Forsberg A, Rollinghoff M (1995) Bacterial evasion of host immune defense: Yersinia enterocolitica encodes a suppressor for tumor necrosis factor alpha expression. Infect Immun 63:1270–1277.
Parmely M, Gale A, Clabaugh M, Horvat R, Zhou WW (1990) Proteolytic inactivation of cytokines by Pseudomonas aeruginosa. Infect Immun 58:3009–3014.
Porat R, Clark BD, Wolff SM, Dinarello CA (1991) Enhancement of growth of virulent strains of Escherichia coli by interleukin-1. Science 254:430–432.
Matuschak GM, Munoz C, Epperly NA, et al (1994) TNF-alpha and IL-6 expression in perfused rat liver after intraportal candidemia vs. E. coli or S. aureus bacteremia. Am J Physiol 267: R446–R454.
Kragsbjerg P, Holmberg H, Vikerfors T (1995) Serum concentrations of interleukin-6, tumour necrosis factor-alpha, and C-reactive protein in patients undergoing major operations. Eur J Surg 161:17–22.
Fisher CJ, Jr, Opal SM, Dhainaut JF, et al (1993) Influence of an anti-tumor necrosis factor monoclonal antibody on cytokine levels in patients with sepsis. The CB0006 Sepsis Syndrome Study Group. Crit Care Med 21:318–327.
Ramamoorthy C, Sasaki SS, Su DL, Sharar SR, Harlan JM, Winn RK (1997) CD 18 adhesion blockade decreases bacterial clearance and neutrophil recruitment after intrapulmonary E. coli but not after S. aureus. J Leukoc Biol 61:167–172.
Karzai W, Von Specht BU, Haberstroh J, Wollersen K (1997) The effects of pretreatment with granulocyte-colony stimulating factor on Escherichia coli and Staphylococcus aureus pneumonia in non-neutropenic rats. Crit Care Med 25: A121 (Abst).
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1999 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Karzai, W., Reinhart, K. (1999). Bacterial Modulation of the Immune Response to Infection and its Consequences. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 1999. Yearbook of Intensive Care and Emergency Medicine, vol 1999. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-662-13453-5_3
Download citation
DOI: https://doi.org/10.1007/978-3-662-13453-5_3
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-65288-5
Online ISBN: 978-3-662-13453-5
eBook Packages: Springer Book Archive